Raymond James Financial Services Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Raymond James Financial Services Advisors’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-1,408	Closed	-$253K	–	2769
2017 Q3	$253K	Sell	1,408 -2,120	-60%	-$295K	﹤0.01%	2127
2017 Q2	$366K	Sell	3,528 -1,488	-30%	-$121K	﹤0.01%	1873
2017 Q1	$394K	Sell	5,016 -16,450	-77%	-$1.02M	﹤0.01%	1718
2016 Q4	$963K	Buy	21,466 +115	+0.5%	+$5.64K	0.01%	1137
2016 Q3	$1.19M	Buy	21,351 +16,610	+350%	+$925K	0.01%	1004
2016 Q2	$237K	Buy	+4,741	New	+$233K	﹤0.01%	1878

Raymond James Financial Services Advisors's KITE Position: Q4 2017 in Review

Raymond James Financial Services Advisors sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,408 shares — an estimated $253K sold.

Raymond James Financial Services Advisors first reported a position in KITE in Q2 2016 and held it in 6 quarters. The position peaked at $1.19M in Q3 2016. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Raymond James Financial Services Advisors reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Raymond James Financial Services Advisors sold 1,408 Kite Pharma, Inc. shares in Q4 2017, an estimated $253K.
Raymond James Financial Services Advisors first reported a position in Kite Pharma, Inc. in Q2 2016 and held it in 6 quarters.
Raymond James Financial Services Advisors's Kite Pharma, Inc. position peaked at $1.19M in Q3 2016.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Raymond James Financial Services Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.